These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Polyvalency: a promising strategy for drug design. Vance D; Shah M; Joshi A; Kane RS Biotechnol Bioeng; 2008 Oct; 101(3):429-34. PubMed ID: 18727104 [TBL] [Abstract][Full Text] [Related]
13. Use of phage display and polyvalency to design inhibitors of protein-protein interactions. Mourez M; Collier RJ Methods Mol Biol; 2004; 261():213-28. PubMed ID: 15064461 [TBL] [Abstract][Full Text] [Related]
14. A comparative structure-function analysis of active-site inhibitors of Vibrio cholerae cholix toxin. Lugo MR; Merrill AR J Mol Recognit; 2015 Sep; 28(9):539-52. PubMed ID: 25756608 [TBL] [Abstract][Full Text] [Related]